Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meletios-Athanasios Dimopoulos

Showing results (211-220 of 283) with videos related to

Pageof 29
Sort By:
British Journal of Haematology|February 28, 2024
Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRF<sup>HisGTG</sup> results in patients' poor treatment outcomeKonstantinos Soureas, Maria-Alexandra Papadimitriou, Panagiotis Malandrakis, et al.
British Journal of Haematology|September 16, 2021
Myeloma patients with COVID-19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccineMaria Gavriatopoulou, Evangelos Terpos, Panagiotis Malandrakis, et al.
Cancers|June 10, 2022
Daratumumab Improves Bone Turnover in Relapsed/Refractory Multiple Myeloma; Phase 2 Study "REBUILD"Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Efstathios Kastritis, et al.
Hormones (Athens, Greece)|October 21, 2022
Patients with type 2 diabetes mellitus present similar immunological response to COVID-19 BNT162b2 mRNA vaccine to healthy subjects: a prospective cohort studyStavroula A Paschou, Vangelis Karalis, Theodora Psaltopoulou, et al.
Scandinavian Journal of Medicine & Science in Sports|January 24, 2025
Effects of Exercise Training on the Bone Marrow Immune Microenvironment and Minimal Residual Disease in Multiple Myeloma Patients Following First-Line TreatmentPolyxeni Spiliopoulou, Pantelis Rousakis, Chrysanthi Panteli, et al.
Sports (Basel, Switzerland)|February 26, 2026
Can Exercise Training Improve the Quality of Life and Physical Function in Multiple Myeloma Patients?: Discussing the Progression of the Training StimulusPolyxeni Spiliopoulou, Evangelos Eleutherakis-Papaiakovou, Magdalini Migkou, et al.
Cancer|June 4, 2011
Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative studyMaria Vassilakopoulou, Thibault de la Motte Rouge, Pierre Colin, et al.
Anaesthesia, Critical Care & Pain Medicine|November 11, 2020
Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens International symposiumJordi Rello, Mirko Belliato, Meletios-Athanasios Dimopoulos, et al.
European Journal of Heart Failure|August 20, 2021
Association of COVID-19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infectionVaia Lambadiari, Asimina Mitrakou, Aikaterini Kountouri, et al.
Thrombosis and Haemostasis|September 22, 2020
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19Grigoris T Gerotziafas, Theodoros N Sergentanis, Guillaume Voiriot, et al.
Pageof 29

Showing results (211-220 of 283) with videos related to

Sort By:
Pageof 29
British Journal of Haematology|February 28, 2024
Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRF<sup>HisGTG</sup> results in patients' poor treatment outcomeKonstantinos Soureas, Maria-Alexandra Papadimitriou, Panagiotis Malandrakis, et al.
British Journal of Haematology|September 16, 2021
Myeloma patients with COVID-19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccineMaria Gavriatopoulou, Evangelos Terpos, Panagiotis Malandrakis, et al.
Cancers|June 10, 2022
Daratumumab Improves Bone Turnover in Relapsed/Refractory Multiple Myeloma; Phase 2 Study "REBUILD"Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Efstathios Kastritis, et al.
Hormones (Athens, Greece)|October 21, 2022
Patients with type 2 diabetes mellitus present similar immunological response to COVID-19 BNT162b2 mRNA vaccine to healthy subjects: a prospective cohort studyStavroula A Paschou, Vangelis Karalis, Theodora Psaltopoulou, et al.
Scandinavian Journal of Medicine & Science in Sports|January 24, 2025
Effects of Exercise Training on the Bone Marrow Immune Microenvironment and Minimal Residual Disease in Multiple Myeloma Patients Following First-Line TreatmentPolyxeni Spiliopoulou, Pantelis Rousakis, Chrysanthi Panteli, et al.
Sports (Basel, Switzerland)|February 26, 2026
Can Exercise Training Improve the Quality of Life and Physical Function in Multiple Myeloma Patients?: Discussing the Progression of the Training StimulusPolyxeni Spiliopoulou, Evangelos Eleutherakis-Papaiakovou, Magdalini Migkou, et al.
Cancer|June 4, 2011
Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative studyMaria Vassilakopoulou, Thibault de la Motte Rouge, Pierre Colin, et al.
Anaesthesia, Critical Care & Pain Medicine|November 11, 2020
Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens International symposiumJordi Rello, Mirko Belliato, Meletios-Athanasios Dimopoulos, et al.
European Journal of Heart Failure|August 20, 2021
Association of COVID-19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infectionVaia Lambadiari, Asimina Mitrakou, Aikaterini Kountouri, et al.
Thrombosis and Haemostasis|September 22, 2020
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19Grigoris T Gerotziafas, Theodoros N Sergentanis, Guillaume Voiriot, et al.
Pageof 29